You are stating that participants will develop metabolic syndrome after 12 weeks? I think I saw somewhere that they could someday look at muscle wasting disorders as well and wasting diseases. Metabolic syndrome changes in that population, weight gain and packing on pounds, could that be viewed as a positive. I think some hip fracture patients might be frail and skinny older folks, that could also be another interesting population. I am sure curious to see these results. Could you cite a source please that states there is short term risks associated with short changes in HDL, or that HDL is used as more than a long term risk factor. Thank you, that would be helpful. I wonder if hypogonadism and fatigue of stopping a steroid will be seen to the extents of other steroids. I also wonder if they lose some of the muscle gains, if they will have changes in mortality rate still, if they had short term gains in muscle mass and become more active quicker and maybe reduce some of the short term risks of hip fracture associated with mortality. Who knows what the data will show though, it sure is hard waiting. I wonder if they would consider longer courses of tteatment or repeat treatment at intervals, if they could show muscle gains but the drop off, or if they would end up having to taper people off these medications slowly. Your articles raise a lot of exciting possibilities and directions, please keep them coming :)
